Edwards TAVI study compendium
In-depth summary of the key Edwards Lifescience TAVI studies.
Heart anatomy guide
Patient guide that helps explain the anatomy and function of the heart.
PARTNER 3 Trial outcomes summary
Infographic comparing SAPIEN 3 TAVI with sAVR in patients with severe aortic stenosis at low surgical risk.
TAVI procedural animation
Transfemoral approach for TAVI using balloon-expandable technology. Available to order as USB.
Aortic stenosis - 3d heart valve model
Tactile models to help patients see and feel the difference between a normal heart valve and one with aortic stenosis.
Aortic stenosis symptom tracker
A patient diary to assist in recording and monitoring symptoms, which can be brought along to future clinical consultations.
Tips for caregivers
A summary of helpful tips for carers and families to support patients living with aortic stenosis.
Patient case study - Low risk 74 year old
74 year old male patient with dyspnea, declining renal function and Parkinson disease.
Patient case study - High risk 72 year old
72 year old female patients with high BMI and severe aortic stenosis.
Patient case study - High risk 85 year old - previous sAVR
85 year old male patient with worsening dspnea, atrial fibrillation and stable declined pulmonary function.
Patients with asymptomatic AS
The importance of identifying and treating patients with asymptomatic aortic stenosis - Professor Prendergast.
Durability of TAVI valves
Current evidence on the durability of TAVI valves - Professor Möllmann.
TAVI durability overview
A summary of the current durability data (up to 8 years) for TAVI valves.
Patient case study - Low risk 81 year old
81 year old male patient with high BMI and a history of atrial fibrillation and prostate cancer - Dr Su-San Liem and Dr Jan Baan.
How low risk AS patients differ from higher risk patients
How do low-risk aortic stenosis patients differ from patients with a higher risk score? Dr Maximilian Scherner.
Aortic stenosis overview
Summarises the aetiology of aortic stenosis and its clinical evaluation, including the ESC/EACTS guidelines and treatment practices.
Healthcare system benefits
A summary of the impact of TAVI on the healthcare system and hospital resources.
What is TAVI? - Brochure For patients
A patient guide that explains the differences between TAVI and surgical valve replacement.
Euro Heart survey results
What are the biggest changes in the results between the Euro Heart survey 2 and 1? - Professor Lung.
Improving the referral pathway in AS
Impulse Study: improving the referral pathway in aortic stenosis - Professor Dr Tanja Rudolph.
The role of the GC within the Heart Team
Diagnoses and management of aortic stenosis - the role of the GC in the Heart Team - Dr Wood.
QoL and clinical outcomes after TAVI
Quality of life and clinical outcomes after sAVR and TAVI - Professor Hendrik Treede.
Improvement of diagnosis & referral
Improvement of diagnoses and the referral pathway for aortic stenosis and GCs - Professor Dr Baumgartner.
Diagnosis and referral best practice
Best practices for diagnosing and referring patients for TAVI - Professor Dr Di Mario.
Evolution of AS treatment
The evolution of aortic stenosis treatment - Professor Dr Baumgartner.
ESC/EACTS 2021 AS guideline flowchart
Graphic summary of the ESC/EACTS 2021 treatment guidelines.